Dr Zhou Lihan, CEO of MiRXES, utilises RNA technology to detect cancer as early as possible.
The post MiRXES early detection tests aims to revolutionise preventive healthcare appeared first on The Peak Magazine.
Dr Zhou Lihan, CEO of MiRXES, utilises RNA technology to detect cancer as early as possible.
The post MiRXES early detection tests aims to revolutionise preventive healthcare appeared first on The Peak Magazine.